MARTIN BERT LEON
Medical Practice in Bethesda, MD
License number
Pennsylvania MD052350L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Bethesda, MD 20817
Pennsylvania
Pennsylvania
Professional information
Inhibiting Development Of Microvessels Within Coronary Or Peripheral Vessel Walls For Restenosis/Atherosclerosis Prevention Or Therapy
US Patent:
2006009, May 4, 2006
Filed:
Dec 6, 2005
Appl. No.:
11/295095
Inventors:
Stephen Epstein - Rockville MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
International Classification:
A61K 38/17, A61K 48/00
US Classification:
514012000, 514044000, 424093200
Abstract:
Disclosed and claimed are compositions and methods for therapy and/or prevention of restenosis and/or atherosclerosis. The compositions can include an agent for inhibiting VEGF and an agent for including vessel maturation; for instance, the soluble VEGF receptor and ang-1. Embodiments can include kits.
Inhibiting Development Of Microvessels Withins Coronary Or Peripheral Vessel Walls For Restenosis/Atherosclerosis Prevention Or Therapy
US Patent:
2003019, Oct 9, 2003
Filed:
Jan 5, 2000
Appl. No.:
09/478621
Inventors:
Stephen Epstein - Rockville MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
Ran Kornowski - Rockville MD, US
Shmuel Fuchs - Rockville MD, US
Martin Leon - Bethesda MD, US
International Classification:
A61K038/17, A61K048/00
US Classification:
514/012000, 514/044000, 424/093200
Abstract:
Disclosed and claimed are compositions and methods for therapy and/or prevention of restenosis and/or atherosclerosis. The compositions can include an agent for inhibiting VEGF and an agent for inducing vessel maturation; for instance, the soluble VEGF receptor and ang-1. Embodiments can include kits.